RAC1 inhibition by azathioprine effectively reduced the self-renewal, colony formation ability of LSCs and prolonged the survival in BCR-ABL1-driven RalA overexpression CML mice. Here, RAC1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.